These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19210880)

  • 1. Serum levels of antibodies to Chlamydia pneumoniae and human HSP60 in giant cell arteritis patients.
    López-Hoyos M; Alvarez L; Ruiz Soto M; Blanco R; José Bartolomé M; Martínez-Taboada VM
    Clin Exp Rheumatol; 2008; 26(6):1107-10. PubMed ID: 19210880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.
    Baerlecken NT; Linnemann A; Gross WL; Moosig F; Vazquez-Rodriguez TR; Gonzalez-Gay MA; Martin J; Kötter I; Henes JC; Melchers I; Vaith P; Schmidt RE; Witte T
    Ann Rheum Dis; 2012 Jun; 71(6):943-7. PubMed ID: 22228484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
    Jafarzadeh A; Esmaeeli-Nadimi A; Shariati M
    Iran J Immunol; 2008 Mar; 5(1):51-6. PubMed ID: 18319525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Chalan P; Rutgers A; Horst G; Huitema MG; Roffel MP; Roozendaal C; Kluin PM; Bos NA; Boots AM; Brouwer E
    Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis].
    Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G
    Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping of antibodies against ferritin heavy chain in giant cell arteritis and polymyalgia rheumatica.
    Große K; Schmidt RE; Witte T; Baerlecken NT
    Scand J Rheumatol; 2013; 42(3):215-9. PubMed ID: 23682607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients.
    Esposito P; Tinelli C; Libetta C; Gabanti E; Rampino T; Dal Canton A
    Cell Stress Chaperones; 2011 Mar; 16(2):219-24. PubMed ID: 20922511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydial antibodies in patients with previous acute anterior uveitis.
    Huhtinen M; Puolakkainen M; Laasila K; Sarvas M; Karma A; Leirisalo-Repo M
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1816-9. PubMed ID: 11431447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunoglobulin G antibodies to chlamydial heat shock protein 60 but not to human and bacterial homologs are associated with coronary artery disease.
    Mahdi OS; Horne BD; Mullen K; Muhlestein JB; Byrne GI
    Circulation; 2002 Sep; 106(13):1659-63. PubMed ID: 12270859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease.
    Ciervo A; Visca P; Petrucca A; Biasucci LM; Maseri A; Cassone A
    Clin Diagn Lab Immunol; 2002 Jan; 9(1):66-74. PubMed ID: 11777831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airflow limitation, asthma, and Chlamydia pneumoniae-specific heat shock protein 60.
    Hahn DL; Peeling RW
    Ann Allergy Asthma Immunol; 2008 Dec; 101(6):614-8. PubMed ID: 19119705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
    Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
    Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica.
    Berthelot JM; Lamour A; Mottier D; Pennec YL; Dueymes M; Jouquan J; Le Goff P; Youinou P
    Ann Med Interne (Paris); 1992; 143(7):429-32. PubMed ID: 1300861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
    Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
    J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Chlamydia pneumoniae infection with heat-shock-protein-60-related response in patients with acute coronary syndrome.
    Hoshida S; Nishino M; Tanouchi J; Kishimoto T; Yamada Y
    Atherosclerosis; 2005 Nov; 183(1):109-12. PubMed ID: 16216593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells.
    Wagner AD; Gérard HC; Fresemann T; Schmidt WA; Gromnica-Ihle E; Hudson AP; Zeidler H
    Arthritis Rheum; 2000 Jul; 43(7):1543-51. PubMed ID: 10902759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications.
    Espinoza LR; Jara LJ; Silveira LH; Martínez-Osuna P; Zwolinska JB; Kneer C; Aguilar JL
    Am J Med; 1991 Apr; 90(4):474-8. PubMed ID: 2012088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency.
    Wirsum C; Glaser C; Gutenberger S; Keller B; Unger S; Voll RE; Vach W; Ness T; Warnatz K
    J Clin Immunol; 2016 May; 36(4):406-12. PubMed ID: 26980224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.